nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepotastine—Nasopharyngitis—Linagliptin—type 2 diabetes mellitus	0.0398	0.0408	CcSEcCtD
Bepotastine—Nasopharyngitis—Rosiglitazone—type 2 diabetes mellitus	0.0305	0.0313	CcSEcCtD
Bepotastine—Nasopharyngitis—Sitagliptin—type 2 diabetes mellitus	0.0248	0.0255	CcSEcCtD
Bepotastine—Nasopharyngitis—Bromocriptine—type 2 diabetes mellitus	0.0225	0.023	CcSEcCtD
Bepotastine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.0172	0.0176	CcSEcCtD
Bepotastine—Rash—Miglitol—type 2 diabetes mellitus	0.017	0.0175	CcSEcCtD
Bepotastine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.017	0.0175	CcSEcCtD
Bepotastine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.0161	0.0165	CcSEcCtD
Bepotastine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.0157	0.0161	CcSEcCtD
Bepotastine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.0156	0.016	CcSEcCtD
Bepotastine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.0156	0.016	CcSEcCtD
Bepotastine—Nasopharyngitis—Metformin—type 2 diabetes mellitus	0.0154	0.0158	CcSEcCtD
Bepotastine—Rash—Tolbutamide—type 2 diabetes mellitus	0.0153	0.0157	CcSEcCtD
Bepotastine—Headache—Tolbutamide—type 2 diabetes mellitus	0.0152	0.0156	CcSEcCtD
Bepotastine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.0151	0.0155	CcSEcCtD
Bepotastine—Nasopharyngitis—Irbesartan—type 2 diabetes mellitus	0.0146	0.0149	CcSEcCtD
Bepotastine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.0145	0.0149	CcSEcCtD
Bepotastine—Rash—Tolazamide—type 2 diabetes mellitus	0.0139	0.0143	CcSEcCtD
Bepotastine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.0139	0.0143	CcSEcCtD
Bepotastine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.0139	0.0142	CcSEcCtD
Bepotastine—Headache—Tolazamide—type 2 diabetes mellitus	0.0139	0.0142	CcSEcCtD
Bepotastine—Rash—Linagliptin—type 2 diabetes mellitus	0.0138	0.0141	CcSEcCtD
Bepotastine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.0138	0.0141	CcSEcCtD
Bepotastine—Headache—Linagliptin—type 2 diabetes mellitus	0.0137	0.0141	CcSEcCtD
Bepotastine—Rash—Acarbose—type 2 diabetes mellitus	0.0134	0.0137	CcSEcCtD
Bepotastine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.0134	0.0137	CcSEcCtD
Bepotastine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.0131	0.0134	CcSEcCtD
Bepotastine—Rash—Nateglinide—type 2 diabetes mellitus	0.0129	0.0132	CcSEcCtD
Bepotastine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.0129	0.0132	CcSEcCtD
Bepotastine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.0125	0.0129	CcSEcCtD
Bepotastine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.0119	0.0122	CcSEcCtD
Bepotastine—Rash—Repaglinide—type 2 diabetes mellitus	0.0112	0.0115	CcSEcCtD
Bepotastine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.0112	0.0115	CcSEcCtD
Bepotastine—Headache—Repaglinide—type 2 diabetes mellitus	0.0111	0.0114	CcSEcCtD
Bepotastine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.0108	0.0111	CcSEcCtD
Bepotastine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.0106	0.0108	CcSEcCtD
Bepotastine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.0106	0.0108	CcSEcCtD
Bepotastine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.0105	0.0108	CcSEcCtD
Bepotastine—Pruritus—Glipizide—type 2 diabetes mellitus	0.0104	0.0106	CcSEcCtD
Bepotastine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0104	0.0106	CcSEcCtD
Bepotastine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.0101	0.0103	CcSEcCtD
Bepotastine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.0101	0.0103	CcSEcCtD
Bepotastine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00968	0.00993	CcSEcCtD
Bepotastine—Rash—Glipizide—type 2 diabetes mellitus	0.00925	0.00949	CcSEcCtD
Bepotastine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00924	0.00948	CcSEcCtD
Bepotastine—Headache—Glipizide—type 2 diabetes mellitus	0.00919	0.00942	CcSEcCtD
Bepotastine—Headache—Pioglitazone—type 2 diabetes mellitus	0.0088	0.00903	CcSEcCtD
Bepotastine—Rash—Glimepiride—type 2 diabetes mellitus	0.00863	0.00885	CcSEcCtD
Bepotastine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00862	0.00884	CcSEcCtD
Bepotastine—Rash—Sitagliptin—type 2 diabetes mellitus	0.0086	0.00882	CcSEcCtD
Bepotastine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0086	0.00882	CcSEcCtD
Bepotastine—Headache—Glimepiride—type 2 diabetes mellitus	0.00858	0.00879	CcSEcCtD
Bepotastine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00855	0.00877	CcSEcCtD
Bepotastine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00832	0.00853	CcSEcCtD
Bepotastine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00799	0.00819	CcSEcCtD
Bepotastine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00779	0.00799	CcSEcCtD
Bepotastine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00778	0.00798	CcSEcCtD
Bepotastine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00774	0.00793	CcSEcCtD
Bepotastine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00747	0.00766	CcSEcCtD
Bepotastine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00717	0.00736	CcSEcCtD
Bepotastine—Rash—Glyburide—type 2 diabetes mellitus	0.00712	0.0073	CcSEcCtD
Bepotastine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00711	0.00729	CcSEcCtD
Bepotastine—Headache—Glyburide—type 2 diabetes mellitus	0.00707	0.00725	CcSEcCtD
Bepotastine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00686	0.00704	CcSEcCtD
Bepotastine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00678	0.00695	CcSEcCtD
Bepotastine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00659	0.00676	CcSEcCtD
Bepotastine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00651	0.00668	CcSEcCtD
Bepotastine—Rash—Gliclazide—type 2 diabetes mellitus	0.00639	0.00655	CcSEcCtD
Bepotastine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00639	0.00655	CcSEcCtD
Bepotastine—Headache—Gliclazide—type 2 diabetes mellitus	0.00635	0.00651	CcSEcCtD
Bepotastine—Pruritus—Metformin—type 2 diabetes mellitus	0.006	0.00615	CcSEcCtD
Bepotastine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.0059	0.00605	CcSEcCtD
Bepotastine—Rash—Valsartan—type 2 diabetes mellitus	0.00587	0.00602	CcSEcCtD
Bepotastine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00587	0.00602	CcSEcCtD
Bepotastine—Headache—Valsartan—type 2 diabetes mellitus	0.00583	0.00598	CcSEcCtD
Bepotastine—Rash—Orlistat—type 2 diabetes mellitus	0.0058	0.00595	CcSEcCtD
Bepotastine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.0058	0.00595	CcSEcCtD
Bepotastine—Headache—Orlistat—type 2 diabetes mellitus	0.00577	0.00591	CcSEcCtD
Bepotastine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00566	0.00581	CcSEcCtD
Bepotastine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00555	0.00569	CcSEcCtD
Bepotastine—Rash—Metformin—type 2 diabetes mellitus	0.00535	0.00548	CcSEcCtD
Bepotastine—Dermatitis—Metformin—type 2 diabetes mellitus	0.00534	0.00548	CcSEcCtD
Bepotastine—Pruritus—Losartan—type 2 diabetes mellitus	0.00533	0.00547	CcSEcCtD
Bepotastine—Headache—Metformin—type 2 diabetes mellitus	0.00531	0.00545	CcSEcCtD
Bepotastine—Rash—Irbesartan—type 2 diabetes mellitus	0.00505	0.00518	CcSEcCtD
Bepotastine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00504	0.00517	CcSEcCtD
Bepotastine—Headache—Irbesartan—type 2 diabetes mellitus	0.00501	0.00514	CcSEcCtD
Bepotastine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00476	0.00488	CcSEcCtD
Bepotastine—Rash—Losartan—type 2 diabetes mellitus	0.00475	0.00487	CcSEcCtD
Bepotastine—Dermatitis—Losartan—type 2 diabetes mellitus	0.00474	0.00487	CcSEcCtD
Bepotastine—Headache—Losartan—type 2 diabetes mellitus	0.00472	0.00484	CcSEcCtD
Bepotastine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00457	0.00469	CcSEcCtD
Bepotastine—Rash—Ramipril—type 2 diabetes mellitus	0.00407	0.00418	CcSEcCtD
Bepotastine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00407	0.00417	CcSEcCtD
Bepotastine—Headache—Ramipril—type 2 diabetes mellitus	0.00405	0.00415	CcSEcCtD
Bepotastine—Domperidone—CYP1A2—type 2 diabetes mellitus	0.00368	0.148	CrCbGaD
Bepotastine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	0.00345	0.139	CrCbGaD
Bepotastine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	0.00299	0.12	CrCbGaD
Bepotastine—Haloperidol—CYP1A2—type 2 diabetes mellitus	0.00281	0.113	CrCbGaD
Bepotastine—Domperidone—CYP3A4—type 2 diabetes mellitus	0.00244	0.0979	CrCbGaD
Bepotastine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	0.00217	0.0873	CrCbGaD
Bepotastine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	0.00188	0.0756	CrCbGaD
Bepotastine—Haloperidol—CYP3A4—type 2 diabetes mellitus	0.00186	0.0747	CrCbGaD
Bepotastine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	0.00185	0.0742	CrCbGaD
Bepotastine—Fentanyl—CYP3A4—type 2 diabetes mellitus	0.00177	0.0709	CrCbGaD
